Phamaceutical Co. New Hire Video

Job #1716

Job Posting Details

Job # 1716 Phamaceutical Co. New Hire Video

Posted Date
Jun 17, 2006 @ 01:02
Respond By
Jun 19, 2006
Word Count
Age Range

Job Description

The following is the narration for a new hire video.


At Roche Palo Alto, we are driven by a passion to discover and develop new medicines for unmet medical needs. We are dedicated to improving the lives of people affected by serious illness and chronic symptoms. Our approach to drug discovery combines the best of two worlds: the small biotechnology companies and the larger, multi-national pharmaceutical firms.

Our focus and integrated approach enables us to find and follow the best research leads in an entrepreneurial and expeditious manner. We enjoy the strong financial support and first-class resources of Roche, a leading, global pharmaceutical and diagnostics company. We benefit from worldwide tools and capabilities, including diverse compound libraries, informatics technologies, and state-of-the-art genomics tools. As one of five Roche pharma research facilities, we pursue complex, long-term scientific goals. We also contribute to, and benefit from, work underway at other Roche research centers.

At Roche Palo Alto, we set ambitious goals and reward achievement. We are committed to pursuing scientific excellence and innovation. Patients matter most to us. We focus on anticipating needs and solving problems early. We are driven by curiosity and activated by the adventure of drug discovery. We move fast, and want to move faster. We encourage informed risk and courageous leadership to drive change.

Our work in Palo Alto is structured to accelerate delivery of novel, high-quality therapeutics into later stage development that demonstrates safety, efficacy and commercial potential. We have a tradition of expertise in small molecule drug discovery -- and have expanded into protein therapeutics. Our charter is to discover and develop compounds through the full development decision point, usually at the end of Phase II studies. Our ultimate intent is that these compounds become clinically differentiated medicines that create value for Roche as a global healthcare leader.

Four key therapy areas are represented in Palo Alto.
One: Viral Diseases.
Two: Inflammation, Autoimmunity and Transplantation.
Three and four are Central Nervous System disorders and Genitourinary disorders, which together form our Neurosciences Group. We are focused on discovering and delivering new medicines to treat patients with the following diseases:

Alzheimer's disease
Hepatitis C
Auto-immune disorders
Overactive bladder
Benign prostatic hyperplasia
Pelvic hypersensitivity
Chronic Bronchitis

Our site and our portfolio of research and development projects are led by a science-driven leadership team. In a true multidisciplinary approach, biology groups in therapeutic and disciplinary functional areas work together with our medicinal chemists to identify promising new targets. Based on data generated by our pre-clinical development group, our clinical researchers combine established and novel approaches to evaluate the clinical safety, tolerability, and beneficial effects of these new medicines in humans.

The culture at Roche Palo Alto is one of learning, independent thinking and openness to new ideas. We hold each individual accountable for delivering results. Our compensation plan and rewards are linked to our success. In addition, we are committed to environmental sustainability and play an active role in our local communities.
Our employees believe in the intrinsic value of the work we do. While the discovery and development of new medicines is a long and demanding process, we are motivated by the opportunity to touch the lives of patients in important and meaningful ways.

We have a tradition of innovation at Roche. We are working to advance science and the understanding of human disease. Research at Palo Alto has led to several new medicines available to patients today.

First introduced in 1995, CellCept® is the leading immunosuppressant prescribed for the prevention of organ transplant rejection.

Valcyte™ is used to preserve the eyesight of AIDS patients infected with cytomegalovirus, a herpes virus that destroys retinal cells and usually leads to blindness.

Aleve® is a naproxen sodium-based, over-the-counter pain reliever that was also discovered and developed on the Roche campus in Palo Alto.

Roche Palo Alto is located on a 70-acre campus in the Stanford Research Park. The site offers a beautiful work setting in addition to recreational amenities including biking and walking trails, a fitness center, and an intriguing collection of art. We are located near several major academic research institutions and numerous leading-edge companies in a region that attracts a highly-educated work force and provides an environment that stimulates innovation.
You are a part of a company with more than a century of commitment to Research and Development. Roche is a global healthcare leader that makes a real difference in people’s lives by improving their health and quality of life.

Roche – We Innovate Healthcare

Ready to get started?

Join the #1 marketplace for voice-over talent

Need Some Help?
Contact us for help with your voice over project.